Global Hemostasis Diagnostics Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
5.90 Million
USD
11.42 Million
2021
2029
 Período de previsão |
2022 –2029 |
 Tamanho do mercado (ano base ) | USD 5.90 Million |
 Tamanho do mercado ( Ano de previsão) | USD 11.42 Million |
 CAGR |
% |
| Principais participantes do mercado |
|
Global Hemostasis Diagnostics Market, By Product (Laboratory Analyzers, Consumables, Point-of-Care Testing Systems), Test Type (Activated Partial Thromboplastin Time, D Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, Activated Clotting Time, Platelet Aggregation Test), End Use (Hospitals/Clinics, Independent Diagnostic Laboratories, Home Care Settings, Others) – Industry Trends and Forecast to 2029.
Hemostasis Diagnostics Market Analysis and Size
Hemostasis diagnostics is a procedure which helps in the detection of hemostatic defects that cause excessive bleeding. The body uses hemostasis as a defence mechanism when it sustains damage. It also helps in the diagnosis of actual cause of these disorders with history and helps in the treatment.
Data Bridge Market Research analyses that the hemostasis diagnostics market which was USD 5.90 million in 2021, is expected to reach USD 11.42 million by 2029, at a CAGR of 8.60% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Hemostasis Diagnostics Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Laboratory Analyzers, Point-of-Care Testing Systems), Test Type (Activated Partial Thromboplastin Time, D Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, Activated Clotting Time, Platelet Aggregation Test), End Use (Hospitals, Diagnostic Centers, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Abbott (U.S.), Thermo Fisher Scientific Inc. (U.S.), HORIBA Europe Holding (Japan), Medtronic (Ireland), Technidyne Corporation (U.S.), BD (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), NIHON KOHDEN CORPORATION (Japan), Haemonetics Corporation (U.S.), Beckman Coulter Inc. (U.S.), Chrono-log Corporation (U.S.), Sysmex Corporation (Japan), Siemens (Germany), Danaher (U.S.) and Grifols S.A. (Spain) |
|
Market Opportunities |
|
Market Definition
Hemostasis is a protective process that the body uses when it is injured. It reduces the blood loss and stops blood flow. The body uses hemostasis as a defence mechanism when it sustains injury. Hemostasis helps with both the treatment of numerous illnesses and the identification of their true causes. From assessing the optical density in a cuvette to spotting clotting factors, hemostasis diagnostics have come a long way.
Global Hemostasis Diagnostics Market Dynamics
Drivers
- Rise in hemophilia
Rising incidences of blood clotting diagnosis for patients, particularly those who are more prone to losing excess blood from the body during surgeries, are major factors driving market growth. According to the National Hemophilia Foundation, haemophilia affected approximately 400,000 people in 2019, and approximately 75% of people with haemophilia around the world continue to receive inadequate treatment or do not have access to treatment. As a result, the market's growth is influenced positively.
- Technological developments
Raising awareness about hemostasis conditions is expected to improve diagnostic rates and preventive care management, resulting in a significant increase in testing volume. The advancement of technology has resulted in the introduction of many novel diagnostic systems and tests, such as the introduction of automated blood coagulation analyzers, which will provide a significant growth opportunity for this market in the coming years.
Opportunities
- Increase in Point-of-Care testing system
Patients and clinicians are more likely to use point-of-care diagnostic tests and rising patient awareness of POC processes is driving market growth. Furthermore, one of the driver is the efficient use of POC devices for diagnosis by minimally skilled professionals. POC development initiatives are also supported by a number of private organizations, including the California Institute of Technology, Dartmouth College, and international organisations. For instance, to enhance professionals' diagnostic testing outside of clinical laboratories, the American Association for Clinical Chemistry developed a certification programme in August 2018. As a result, the market is anticipated to increase profitably during the forecast period.
Restraints/Challenges
- Stringent government regulations
Stringent government regulation and lack of awareness regarding hemostasis disorders in underdeveloped regions will obstruct the market's growth rate.
This hemostasis diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hemostasis diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Hemostasis Diagnostics Market Scope
The hemostasis diagnostics market is segmented on the basis of product, test type and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Laboratory Analyzers
- Point-of-Care Testing Systems
Test Type
- Activated Partial Thromboplastin Time
- D Dimer Test
- Fibrinogen Test
- Prothrombin Time (PT) Test
- Activated Clotting Time
- Platelet Aggregation Test
End Use
- Hospitals
- Diagnostic Centers
- Others
Hemostasis Diagnostics Market Regional Analysis/Insights
The hemostasis diagnostics market is analysed and market size insights and trends are provided by country, product, test type and end use as referenced above.
The countries covered in the hemostasis diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the hemostasis diagnostics market due to the rising prevalence of surgeries, increasing R&D activities and organ transplant procedures and developed healthcare infrastructure in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the rising awareness regarding hemostasis.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Hemostasis Diagnostics Market Share Analysis
The hemostasis diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hemostasis diagnostics market.
Some of the major players operating in the hemostasis diagnostics market are:
- Abbott (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- HORIBA Europe Holding (Japan)
- Medtronic (Ireland)
- Technidyne Corporation (U.S.)
- BD (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- NIHON KOHDEN CORPORATION (Japan)
- Haemonetics Corporation (U.S.)
- Beckman Coulter Inc. (U.S.)
- Chrono-log Corporation (U.S.)
- Sysmex Corporation (Japan)
- Siemens (Germany)
- Danaher (U.S.)
- Grifols S.A. (Spain)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
